Why It’s Hard to Make Vaccines: Explained

Video Credit: Wibbitz Top Stories
Published on January 28, 2021 - Duration: 01:09s

Why It’s Hard to Make Vaccines: Explained

Why It’s Hard to Make Vaccines: Explained.

With the high demand for the COVID-19 vaccine, its rollout has undergone massive delays around the globe.

Here are some reasons why vaccine production has taken longer than expected.

Creating large amounts of mRNA takes time, University of Pennsylvania’s Dr. Drew Weissman says, “prior to this, nobody made a billion doses ... or even a million doses of mRNA.” .

Production can’t begin without raw materials, If even one item is missing, production has to be delayed “and that capacity will be lost forever,” says Moderna CEO Stéphane Bancel.

Batches sometimes fall short, Working with biological ingredients leaves room for variability and can result in fewer doses than expected.

Quality assurance takes time, Every vaccine is produced under strict rules, including inspections and testing throughout the process, which may cause delays


You are here

Related videos from verified sources

Covid-19: what will it take to vaccinate the world? 09:51
Video credit: The Economist - Published on January 27, 2021 

COVID In New Jersey: Careful Planning Has Helped Essex County Vaccination Site Become Highly Efficient 01:59
Video credit: CBS 2 New York - Published on January 23, 2021 

Essex County Leaders Working Hard To Get COVID Vaccines Out Quickly 01:59
Video credit: CBS 2 New York - Published on January 22, 2021 

You might like